Lipigon Pharmaceuticals AB (OSTO:LPGO) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB Days Payable?

Lipigon Pharmaceuticals AB's average Accounts Payable for the three months ended in Dec. 2023 was kr1.94 Mil. Lipigon Pharmaceuticals AB's Cost of Goods Sold for the three months ended in Dec. 2023 was kr0.00 Mil.

The historical rank and industry rank for Lipigon Pharmaceuticals AB's Days Payable or its related term are showing as below:

OSTO:LPGO's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.12
* Ranked among companies with meaningful Days Payable only.

Lipigon Pharmaceuticals AB's Days Payable stayed the same from Sep. 2022 (0.00) to Dec. 2023 (0.00). stayed the same

Lipigon Pharmaceuticals AB Days Payable Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB Days Payable Chart

Lipigon Pharmaceuticals AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Lipigon Pharmaceuticals AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Lipigon Pharmaceuticals AB's Days Payable

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipigon Pharmaceuticals AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's Days Payable falls into.

Lipigon Pharmaceuticals AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Lipigon Pharmaceuticals AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (3.487	+	2.433)	/	2 )	/	0	*	365
=	2.96					/	0	*	365
=	N/A

Lipigon Pharmaceuticals AB's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (1.445	+	2.433)	/	2 )	/	0	*	365 / 4
=	1.939					/	0	*	365 / 4
=	N/A

Lipigon Pharmaceuticals AB Days Payable Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

9RP:Germany

Address

Tvistevagen 48 C, Umea, SWE, 90736

Website

https://www.lipigon.se

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines